COVI-MAB

Welcome to the Brand page for “COVI-MAB”, which is offered here for Pharmaceutical preparations for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of covid-19/coronavirus;covid mab;.

Its status is currently believed to be active. Its class is unavailable. “COVI-MAB” is believed to be currently owned by “SORRENTO THERAPEUTICS, INC.”